Trials / Recruiting
RecruitingNCT06423729
Effect of Nicorandil in Type 2 Diabetic Obese Patients
Clinical Study Evaluating the Effect of Nicorandil in Type 2 Diabetic Obese Patients Treated With Sulfonylurea
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicorandil 10 MG | Patients will receive oral Nicorandil 10 MG twice daily in addition to 2nd generation sulfonylureas , for 3 months. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2024-12-01
- Completion
- 2025-01-01
- First posted
- 2024-05-21
- Last updated
- 2024-05-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06423729. Inclusion in this directory is not an endorsement.